Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 22 | 2024 | 278 | 4.990 |
Why?
|
| Trypanosoma cruzi | 20 | 2024 | 221 | 4.060 |
Why?
|
| Ascariasis | 2 | 2024 | 59 | 1.150 |
Why?
|
| Protozoan Vaccines | 3 | 2024 | 85 | 1.140 |
Why?
|
| Vaccines | 4 | 2024 | 354 | 1.070 |
Why?
|
| Leishmaniasis | 1 | 2024 | 32 | 0.940 |
Why?
|
| Microbiota | 4 | 2024 | 392 | 0.870 |
Why?
|
| RNA, Messenger | 4 | 2024 | 2826 | 0.860 |
Why?
|
| Probiotics | 1 | 2024 | 209 | 0.780 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2020 | 6 | 0.730 |
Why?
|
| Parasites | 1 | 2020 | 28 | 0.710 |
Why?
|
| Immunity, Innate | 2 | 2024 | 374 | 0.700 |
Why?
|
| Rhodnius | 2 | 2017 | 2 | 0.690 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 1703 | 0.640 |
Why?
|
| Virulence Factors | 2 | 2023 | 171 | 0.620 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 122 | 0.600 |
Why?
|
| DNA, Protozoan | 2 | 2018 | 28 | 0.600 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2023 | 176 | 0.580 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 479 | 0.580 |
Why?
|
| Plant Leaves | 1 | 2017 | 43 | 0.550 |
Why?
|
| Macrophages | 1 | 2020 | 611 | 0.540 |
Why?
|
| Insect Vectors | 1 | 2017 | 109 | 0.520 |
Why?
|
| Cytokines | 3 | 2018 | 1272 | 0.510 |
Why?
|
| Animals | 24 | 2024 | 33730 | 0.460 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 479 | 0.450 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2021 | 42 | 0.400 |
Why?
|
| Host-Parasite Interactions | 2 | 2024 | 63 | 0.390 |
Why?
|
| Adjuvants, Immunologic | 2 | 2024 | 359 | 0.390 |
Why?
|
| Mice, Inbred BALB C | 7 | 2021 | 979 | 0.340 |
Why?
|
| Mice | 14 | 2024 | 17552 | 0.300 |
Why?
|
| Antigens, Protozoan | 2 | 2024 | 62 | 0.280 |
Why?
|
| Technology | 2 | 2024 | 64 | 0.270 |
Why?
|
| Arecaceae | 2 | 2017 | 2 | 0.270 |
Why?
|
| Recombinant Proteins | 4 | 2023 | 1370 | 0.260 |
Why?
|
| Metabolome | 2 | 2020 | 292 | 0.250 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 414 | 0.250 |
Why?
|
| Horses | 2 | 2023 | 89 | 0.240 |
Why?
|
| Prebiotics | 1 | 2024 | 22 | 0.240 |
Why?
|
| Ascaris suum | 1 | 2024 | 22 | 0.240 |
Why?
|
| Transfection | 2 | 2024 | 1076 | 0.230 |
Why?
|
| Saccharomycetales | 2 | 2021 | 31 | 0.230 |
Why?
|
| Rhodococcus equi | 1 | 2023 | 4 | 0.230 |
Why?
|
| Larva | 1 | 2024 | 229 | 0.230 |
Why?
|
| RNA Caps | 1 | 2024 | 31 | 0.230 |
Why?
|
| Myocarditis | 2 | 2015 | 119 | 0.230 |
Why?
|
| Actinomycetales Infections | 1 | 2023 | 12 | 0.230 |
Why?
|
| Horse Diseases | 1 | 2023 | 31 | 0.220 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 107 | 0.220 |
Why?
|
| Trypanocidal Agents | 1 | 2023 | 27 | 0.220 |
Why?
|
| Parasite Load | 2 | 2020 | 25 | 0.220 |
Why?
|
| Tissue Distribution | 1 | 2024 | 382 | 0.220 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 89 | 0.220 |
Why?
|
| Nitroimidazoles | 1 | 2023 | 52 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 369 | 0.210 |
Why?
|
| Immune System | 1 | 2023 | 86 | 0.210 |
Why?
|
| Molecular Typing | 3 | 2017 | 33 | 0.200 |
Why?
|
| Models, Animal | 1 | 2024 | 465 | 0.200 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 298 | 0.200 |
Why?
|
| Colombia | 3 | 2017 | 48 | 0.200 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.190 |
Why?
|
| Humans | 20 | 2024 | 122349 | 0.190 |
Why?
|
| Zebrafish | 1 | 2024 | 369 | 0.190 |
Why?
|
| Nasal Sprays | 1 | 2021 | 8 | 0.190 |
Why?
|
| Tropism | 1 | 2020 | 8 | 0.190 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 47 | 0.180 |
Why?
|
| Death, Sudden | 1 | 2021 | 46 | 0.180 |
Why?
|
| NADPH Oxidase 2 | 1 | 2020 | 40 | 0.180 |
Why?
|
| Vero Cells | 1 | 2020 | 111 | 0.180 |
Why?
|
| RNA | 1 | 2024 | 578 | 0.180 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 91 | 0.180 |
Why?
|
| Phylogeny | 3 | 2018 | 681 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4288 | 0.170 |
Why?
|
| Myocardium | 3 | 2020 | 981 | 0.170 |
Why?
|
| Gene Expression | 2 | 2021 | 1579 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 217 | 0.170 |
Why?
|
| Heart | 2 | 2021 | 723 | 0.160 |
Why?
|
| Transients and Migrants | 2 | 2016 | 24 | 0.160 |
Why?
|
| Genome, Protozoan | 1 | 2018 | 26 | 0.160 |
Why?
|
| DNA | 1 | 2024 | 1606 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2021 | 418 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2020 | 741 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2020 | 404 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 398 | 0.150 |
Why?
|
| Tenericutes | 1 | 2017 | 3 | 0.150 |
Why?
|
| Multigene Family | 1 | 2018 | 299 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 469 | 0.150 |
Why?
|
| Thymocytes | 1 | 2017 | 7 | 0.140 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 10 | 0.140 |
Why?
|
| Insect Control | 1 | 2017 | 13 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3771 | 0.140 |
Why?
|
| Thymus Gland | 1 | 2017 | 101 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1003 | 0.140 |
Why?
|
| Ecosystem | 1 | 2017 | 76 | 0.140 |
Why?
|
| Protein Domains | 3 | 2021 | 228 | 0.130 |
Why?
|
| Arginine | 1 | 2018 | 302 | 0.130 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2015 | 8 | 0.130 |
Why?
|
| Anthocyanins | 1 | 2015 | 4 | 0.130 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 481 | 0.130 |
Why?
|
| Cell Line | 1 | 2020 | 2782 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2015 | 76 | 0.120 |
Why?
|
| Phenols | 1 | 2015 | 57 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 515 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 394 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 158 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2015 | 117 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 3 | 2023 | 454 | 0.110 |
Why?
|
| Base Sequence | 1 | 2018 | 3109 | 0.110 |
Why?
|
| Fruit | 1 | 2015 | 216 | 0.110 |
Why?
|
| Genotype | 2 | 2017 | 2525 | 0.110 |
Why?
|
| Trypanosomiasis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Chiroptera | 1 | 2013 | 13 | 0.110 |
Why?
|
| HIV Infections | 1 | 2024 | 1858 | 0.100 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 1131 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1935 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2023 | 1007 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 4366 | 0.080 |
Why?
|
| Female | 9 | 2024 | 64923 | 0.060 |
Why?
|
| Bolivia | 2 | 2016 | 14 | 0.060 |
Why?
|
| Spain | 2 | 2016 | 53 | 0.060 |
Why?
|
| Lung | 2 | 2024 | 1477 | 0.060 |
Why?
|
| Endemic Diseases | 2 | 2016 | 56 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 98 | 0.060 |
Why?
|
| Hepatomegaly | 1 | 2023 | 23 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2023 | 54 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2021 | 1167 | 0.060 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 68 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 179 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 323 | 0.050 |
Why?
|
| Alum Compounds | 1 | 2022 | 35 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 506 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 118 | 0.050 |
Why?
|
| Hybridomas | 1 | 2021 | 41 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2021 | 9 | 0.050 |
Why?
|
| Feces | 1 | 2024 | 705 | 0.050 |
Why?
|
| Antibodies, Protozoan | 1 | 2021 | 64 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2021 | 53 | 0.050 |
Why?
|
| Bacteria | 1 | 2024 | 478 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 758 | 0.050 |
Why?
|
| Vaccines, DNA | 1 | 2021 | 51 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 576 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 192 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 97 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 181 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 887 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 751 | 0.040 |
Why?
|
| Genes, Protozoan | 1 | 2018 | 25 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 517 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 874 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 2373 | 0.040 |
Why?
|
| Phytoplasma | 1 | 2017 | 1 | 0.040 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2017 | 2 | 0.040 |
Why?
|
| Plasma | 1 | 2018 | 96 | 0.040 |
Why?
|
| Liver | 1 | 2024 | 1852 | 0.040 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 673 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2017 | 123 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2018 | 439 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2017 | 90 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2674 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 221 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 907 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1067 | 0.030 |
Why?
|
| Ecuador | 1 | 2015 | 11 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1022 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2015 | 5 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 34 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 318 | 0.030 |
Why?
|
| Cresols | 1 | 2014 | 6 | 0.030 |
Why?
|
| Sulfuric Acid Esters | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3074 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 810 | 0.030 |
Why?
|
| United States | 2 | 2024 | 10494 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 27 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1468 | 0.030 |
Why?
|
| Coinfection | 1 | 2016 | 170 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2014 | 20 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1296 | 0.030 |
Why?
|
| Ecology | 1 | 2013 | 12 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 184 | 0.030 |
Why?
|
| Trypanosoma | 1 | 2013 | 9 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 141 | 0.030 |
Why?
|
| Antioxidants | 1 | 2015 | 337 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1678 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 963 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2013 | 221 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2010 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 2945 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 395 | 0.020 |
Why?
|
| Adult | 3 | 2016 | 28764 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3865 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 1462 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1750 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 4643 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3302 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12049 | 0.010 |
Why?
|
| Male | 2 | 2016 | 59559 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 25655 | 0.010 |
Why?
|